Web$MCRB - Seres Therapeutics, Inc. (MCRB) Q3 2024 Earnings Call Transcript. Seres Therapeutics Inc Mcrb Q3 2024 Earnings Call Transcript By Seekingalpha By By By Reuters By Yahoo Finance Seres Therapeutics to Present at Canaccord Genuity 42nd Annual Growth Conference By Yahoo Finance Web14 apr. 2024 · Wells Fargo (WFC) delivered earnings and revenue surprises of 6.96% and 3.24%, ... Seres Therapeutics (MCRB) was a big mover last session on higher-than-average trading volume.
MCRB - Seres Therapeutics Inc Stock Price Quote - Morningstar
Web11 apr. 2024 · According to the issued ratings of 5 analysts in the last year, the consensus rating for Seres Therapeutics stock is Buy based on the current 5 buy ratings for MCRB. The average twelve-month price prediction for Seres Therapeutics is $16.25 with a high price target of $25.00 and a low price target of $12.00. Learn more on MCRB's analyst … Web11 apr. 2024 · What's Happening With MCRB Stock Today? Seres Therapeutics Inc (MCRB) stock is trading at $5.85 as of 1:15 PM on Tuesday, Apr 11, an increase of $0.17, or 3.09% from the previous closing price of $5.67. The stock has traded between $5.76 and $6.00 so far today. Volume today is 1,291,853 compared to average volume of 1,328,405. first childrens finance logo
MCRB Next Earnings Date
WebTable displays both upcoming quarterly earnings dates and historical release dates. ... (MCRB). Stocks Features Premarket Trading After Hours Trading Market Movers 52 … Web3 aug. 2024 · Seres Therapeutics, Inc. (NASDAQ:NASDAQ:MCRB) Q2 2024 Earnings Conference Call August 3, 2024 8:30 AM ETCompany ParticipantsCarlo Tanzi - Head of … WebSee the latest earnings results for MCRB, Explore Seres Therapeutics Inc's earnings history, its beat/miss ratio and find out the outlook for next earnings reports. first children services glassdoor